SCHEMBL5348134

SCHEMBL5348134

Cc1c(C)c(N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c(C)c2c1OC(C)(C)C2N1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
AKR1C3 P42330 1/20 0.35
CA12 O43570 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
HTR7 P34969 1/20 0.33
ADAMTS5 Q9UNA0 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HRH4 Q9H3N8 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
HSD11B1 P28845 1/20 0.31
DHFR P00374 1/20 0.31
MMP2 P08253 2/20 0.31
MMP13 P45452 2/20 0.31
PPARD Q03181 1/20 0.31
SLC6A9 P48067 1/20 0.31
PHGDH O43175 2/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14492155 0.88 ALDH1A1 (0.42) ALDH1A1MAPTSMN1; SMN2DHFR
Hydrochloric Acid SCHEMBL5351235 0.87 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2DHFR
SCHEMBL14492156 0.86 ALDH1A1 (0.43) ALDH1A1HTR7MAPTDHFR
Hydrochloric Acid SCHEMBL5349403 0.85 ALDH1A1 (0.42) ALDH1A1HTR7MAPTDHFR
SCHEMBL5344095 0.84 ALDH1A1 (0.40) ALDH1A1AKR1C3HTR7MAPTSMN1; SMN2
SCHEMBL2476247 0.84 AKR1C3 (0.39) AKR1C3CA12CA2CA9HTR7
SCHEMBL5355435 0.83 ALDH1A1 (0.40) ALDH1A1AKR1C3HTR7MAPTSMN1; SMN2
SCHEMBL2471718 0.80 CA12 (0.36) AKR1C3CA12CA2CA9HTR7
SCHEMBL5340867 0.80 ALDH1A1 (0.39) ALDH1A1HTR7CYP3A4
SCHEMBL5343639 0.79 ALDH1A1 (0.38) ALDH1A1HTR7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use OHKAWA SHIGENORI 2007-06-28 US disclosed
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use OHKAWA SHIGENORI 2007-06-28 US disclosed
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use OHKAWA SHIGENORI 2007-06-28 US disclosed
US-7208495-B2 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-04-24 US disclosed
US-20040167171-A1 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-26 US disclosed
EP-1411052-A1 BENZO-FUSED 5-MEMBERED HETROCYCLE COMPOUNDS,PROCESS FOR PREPARATION OF THE SAME, AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use CBR1, DBH, PARK7 ALDH1A1 1019/4885AKR1C3 344/4885CA12 2876/4885
US-20040167171-A1 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof CYP8B1, PARK7, OXER1 ALDH1A1 1308/4885AKR1C3 343/4885CA12 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.